Get started
Author

Jennifer L. Yori

Observed names: Jennifer L Yori, Jennifer Yori
Institution: Sarah Cannon
OpenAlex ID: A5079757706
Krüppel-like Factor 4 Inhibits Epithelial-to-Mesenchymal Transition through Regulation of E-cadherin Gene Expression
2010 · Jennifer L. Yori, Emhonta Johnson, et al. · Journal of Biological Chemistry · 162
PDF
Krüppel-like Factor 4 Inhibits Tumorigenic Progression and Metastasis in a Mouse Model of Breast Cancer
2011 · Jennifer L Yori, Darcie D Seachrist, et al. · Neoplasia · 124
PDF
Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases
2016 · Jennifer M. Sahni, Sylvia S. Gayle, et al. · Journal of Biological Chemistry · 58
PDF
Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2014 · Jennifer L. Yori, Kristen L. Lozada, et al. · Cancer Research · 35
Biomarker testing in early-stage NSCLC: Results from the MYLUNG Consortium.
2024 · Makenzi Colleen Evangelist, James Edward Butrynski, et al. · Journal of Clinical Oncology · 4
Biomarker Testing Rates and Patterns in Patients With Metastatic Non–Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices
2026 · Makenzi Evangelist, Bo Wang, et al. · JCO Precision Oncology · 1
PDF
Correction: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases.
2020 · Jennifer M. Sahni, Sylvia S. Gayle, et al. · Journal of Biological Chemistry · 1
PDF
Testing and treatment patterns in KRAS mutant mNSCLC: Results from the MYLUNG Consortium.
2025 · Bo Wang, Makenzi Colleen Evangelist, et al. · Journal of Clinical Oncology
PDF
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
2023 · Jennifer L. Yori, Kristen L. Lozada, et al.
Works count: 31
Citation count: 385
H-index: 4
I10-index: 4
Year
Topic
Type